» Articles » PMID: 26157589

Impact of an Antimicrobial Stewardship Program on Unnecessary Double Anaerobic Coverage Prescription

Overview
Date 2015 Jul 10
PMID 26157589
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Co-administration of two or more antimicrobials with anti-anaerobic activity is not recommended except in certain circumstances. We therefore conducted an intervention to reduce unnecessary double anaerobic coverage (DAC) prescription.

Materials And Methods: The intervention consisted of education using an institutional intranet and prospective audits and feedback provided through collaboration between a pharmacist and an infectious diseases physician in Seoul National University Bundang Hospital, a tertiary hospital in Seongnam, Republic of Korea, in 2013. The study period was 1 year which contained 6 months of pre-intervention period and 6 months of intervention period. To estimate the overall effect of the intervention, we compared the monthly number of patients receiving unnecessary DAC for more than 3 days and the proportion of patients receiving unnecessary DAC for more than 3 days among all patients receiving DAC.

Results: The average monthly number of patients receiving unnecessary DAC for more than 3 days after screening decreased by 73.9% in the intervention period from 26.8 to 7.0. Wilcoxon rank sum test revealed there was a significant statistical difference in the monthly number of patients receiving unnecessary DAC for more than 3 days (P = 0.005). The proportion of patients receiving unnecessary DAC for more than 3 days after screening among all patients identified as receiving necessary or unnecessary DAC also decreased by 67.8% in the intervention period from 42.3% to 13.6% (P < 0.001).

Conclusion: The multidisciplinary antimicrobial stewardship program with combined methods reduced unnecessary DAC prescription successfully.

Citing Articles

"Antimicrobial utilization in a paediatric intensive care unit in India: A step towards strengthening antimicrobial stewardship practices".

Singh M, Gaikwad N, Keche Y, Jindal A, Dhaneria S, Gurunthalingam M PLoS One. 2024; 19(9):e0310515.

PMID: 39298455 PMC: 11412675. DOI: 10.1371/journal.pone.0310515.


Implementing antimicrobial stewardship: lessons and perspectives from a university-affiliated tertiary hospital in Korea.

Lee S, Lee R, Cho S, Nho D, Ahn H, Lee D Korean J Intern Med. 2024; 39(3):399-412.

PMID: 38715230 PMC: 11076883. DOI: 10.3904/kjim.2023.504.


Quantitative and qualitative evaluation of antimicrobial usage: the first step for antimicrobial stewardship.

Moon S, Kim B, Kim H Korean J Intern Med. 2024; 39(3):383-398.

PMID: 38715229 PMC: 11076899. DOI: 10.3904/kjim.2023.506.


Core Elements for Implementing Antimicrobial Stewardship Programs in Korean General Hospitals.

Cheong H, Park K, Kim H, Kim S, Kim B, Moon C Infect Chemother. 2023; 54(4):637-673.

PMID: 36596679 PMC: 9840955. DOI: 10.3947/ic.2022.0171.


The role of the clinical pharmacist in antimicrobial stewardship in Asia: A review.

Jantarathaneewat K, Camins B, Apisarnthanarak A Antimicrob Steward Healthc Epidemiol. 2022; 2(1):e176.

PMID: 36386007 PMC: 9641507. DOI: 10.1017/ash.2022.310.


References
1.
Kazmier F . A significant interaction between metronidazole and warfarin. Mayo Clin Proc. 1976; 51(12):782-4. View

2.
Brown K, Khanafer N, Daneman N, Fisman D . Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013; 57(5):2326-32. PMC: 3632900. DOI: 10.1128/AAC.02176-12. View

3.
Dellit T, Owens R, McGowan Jr J, Gerding D, Weinstein R, Burke J . Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2006; 44(2):159-77. DOI: 10.1086/510393. View

4.
Girotti M, Fodoruk S, Rotstein O . Antibiotic handbook and pre-printed perioperative order forms for surgical antibiotic prophylaxis: do they work?. Can J Surg. 1990; 33(5):385-8. View

5.
Kapoor K, Chandra M, Nag D, Paliwal J, Gupta R, Saxena R . Evaluation of metronidazole toxicity: a prospective study. Int J Clin Pharmacol Res. 2000; 19(3):83-8. View